Global changes in gene expression by the opportunistic pathogen Burkholderia cenocepacia in response to internalization by murine macrophages

BMC Genomics

Volumn 13, Issue 1, 2012, Pages

  Tolman, Jennifer S ^a   Valvano, Miguel A ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADAPTATION; ANIMAL CELL; ARTICLE; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL SURVIVAL; BURKHOLDERIA CENOCEPACIA; CONTROLLED STUDY; CYTOTOXICITY; DNA LIBRARY; GENE CONTROL; GENE DELETION; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE TARGETING; HOST CELL; HOST PATHOGEN INTERACTION; INTERNALIZATION; MACROPHAGE; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; SELECTIVE CAPTURE OF TRANSCRIBED SEQUENCE; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TYPE VI SECRETION SYSTEM; ANIMAL; BURKHOLDERIA INFECTION; CELL LINE; DNA MICROARRAY; DNA SEQUENCE; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; MICROBIOLOGY; PHAGOCYTOSIS; PHAGOSOME; UPREGULATION;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CENOCEPACIA; MURINAE;

TRANSCRIPTOME;

ANIMALS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA INFECTIONS; CELL LINE; DOWN-REGULATION; GENE EXPRESSION REGULATION, BACTERIAL; MACROPHAGES; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PHAGOCYTOSIS; PHAGOSOMES; SEQUENCE ANALYSIS, DNA; TRANSCRIPTOME; UP-REGULATION;

EID: 84856772014     PISSN: None     EISSN: 14712164     Source Type: Journal    
DOI: 10.1186/1471-2164-13-63     Document Type: Article

References (78)

1. Vanlaere E, Baldwin A, Gevers D, Henry D, De Brandt E, LiPuma JJ, Mahenthiralingam E, Speert DP, Dowson C, Vandamme P. Taxon K, a complex within the Burkholderia cepacia complex, comprises at least two novel species, Burkholderia contaminans sp. nov. and Burkholderia lata sp. nov. Int J Syst Evol Microbiol 2009, 59(Pt 1):102-111.
2. Vanlaere E, Lipuma JJ, Baldwin A, Henry D, De Brandt E, Mahenthiralingam E, Speert D, Dowson C, Vandamme P. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int J Syst Evol Microbiol 2008, 58(Pt 7):1580-1590.
3. Coenye T, Vandamme P. Diversity and significance of Burkholderia species occupying diverse ecological niches. Environ Microbiol 2003, 5(9):719-729. 10.1046/j.1462-2920.2003.00471.x, 12919407.
4. Vial L, Chapalain A, Groleau MC, Deziel E. The various lifestyles of the Burkholderia cepacia complex species: a tribute to adaptation. Environ Microbiol 2011, 13(1):1-12. 10.1111/j.1462-2920.2010.02343.x, 20880095.
5. Holmes A, Govan J, Goldstein R. Agricultural use of Burkholderia (Pseudomonas) cepacia: a threat to human health?. Emerg Infect Dis 1998, 4(2):221-227. 10.3201/eid0402.980209, 2640135, 9621192.
6. Krumme ML, Timmis KN, Dwyer DF. Degradation of trichloroethylene by Pseudomonas cepacia G4 and the constitutive mutant strain G4 5223 PR1 in aquifer microcosms. Appl Environ Microbiol 1993, 59(8):2746-2749. 182353, 7690223.
7. Govan JR, Hughes JE, Vandamme P. Burkholderia cepacia: medical, taxonomic and ecological issues. J Med Microbiol 1996, 45(6):395-407. 10.1099/00222615-45-6-395, 8958242.
8. Isles A, Maclusky I, Corey M, Gold R, Prober C, Fleming P, Levison H. Pseudomonas cepacia infection in cystic fibrosis: an emerging problem. J Pediatr 1984, 104:206-210. 10.1016/S0022-3476(84)80993-2, 6420530.
9. Corey M, Farewell V. Determinants of mortality from cystic fibrosis in Canada, 1970-1989. Am J Epidemiol 1996, 143(10):1007-1017.
10. Waters V, Ratjen F. Multidrug-resistant organisms in cystic fibrosis: management and infection-control issues. Expert Rev Anti Infect Ther 2006, 4(5):807-819. 10.1586/14787210.4.5.807, 17140357.
11. Govan JR, Brown PH, Maddison J, Doherty CJ, Nelson JW, Dodd M, Greening AP, Webb AK. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342(8862):15-19. 10.1016/0140-6736(93)91881-L, 7686239.
12. LiPuma JJ, Spilker T, Coenye T, Gonzalez CF. An epidemic Burkholderia cepacia complex strain identified in soil. Lancet 2002, 359(9322):2002-2003. 10.1016/S0140-6736(02)08836-0, 12076559.
13. LiPuma JJ, Dasen SE, Nielson DW, Stern RC, Stull TL. Person-to-person transmission of Pseudomonas cepacia between patients with cystic fibrosis. Lancet 1990, 336:1094-1096. 10.1016/0140-6736(90)92571-X, 1977981.
14. Reik R, Spilker T, Lipuma JJ. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J Clin Microbiol 2005, 43(6):2926-2928. 10.1128/JCM.43.6.2926-2928.2005, 1151955, 15956421.
15. Speert DP, Henry D, Vandamme P, Corey M, Mahenthiralingam E. Epidemiology of Burkholderia cepacia complex in patients with cystic fibrosis, Canada. Emerg Infect Dis 2002, 8(2):181-187.
16. Courtney JM, Dunbar KE, McDowell A, Moore JE, Warke TJ, Stevenson M, Elborn JS. Clinical outcome of Burkholderia cepacia complex infection in cystic fibrosis adults. J Cyst Fibros 2004, 3(2):93-98. 10.1016/j.jcf.2004.01.005, 15463892.
17. Baldwin A, Mahenthiralingam E, Drevinek P, Vandamme P, Govan JR, Waine DJ, LiPuma JJ, Chiarini L, Dalmastri C, Henry DA, et al. Environmental Burkholderia cepacia complex isolates in human infections. Emerg Infect Dis 2007, 13(3):458-461. 10.3201/eid1303.060403, 2725883, 17552100.
18. Holden MT, Seth-Smith HM, Crossman LC, Sebaihia M, Bentley SD, Cerdeno-Tarraga AM, Thomson NR, Bason N, Quail MA, Sharp S, et al. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J Bacteriol 2009, 191(1):261-277. 10.1128/JB.01230-08, 2612433, 18931103.
19. Loutet SA, Valvano MA. A decade of Burkholderia cenocepacia virulence determinant research. Infect Immun 2010, 78(10):4088-4100. 10.1128/IAI.00212-10, 2950345, 20643851.
20. Sajjan US, Yang JH, Hershenson MB, LiPuma JJ. Intracellular trafficking and replication of Burkholderia cenocepacia in human cystic fibrosis airway epithelial cells. Cell Microbiol 2006, 8(9):1456-1466. 10.1111/j.1462-5822.2006.00724.x, 16922864.
21. Lamothe J, Huynh KK, Grinstein S, Valvano MA. Intracellular survival of Burkholderia cenocepacia in macrophages is associated with a delay in the maturation of bacteria-containing vacuoles. Cell Microbiol 2007, 9(1):40-53. 10.1111/j.1462-5822.2006.00766.x, 16869828.
22. Martin DW, Mohr CD. Invasion and intracellular survival of Burkholderia cepacia. Infect Immun 2000, 68(1):24-29. 10.1128/IAI.68.1.24-29.2000, 97097, 10603364.
23. Saini LS, Galsworthy SB, John MA, Valvano MA. Intracellular survival of Burkholderia cepacia complex isolates in the presence of macrophage cell activation. Microbiology 1999, 145(Pt 12):3465-3475.
24. Saldias MS, Valvano MA. Interactions of Burkholderia cenocepacia and other Burkholderia cepacia complex bacteria with epithelial and phagocytic cells. Microbiology 2009, 155(Pt 9):2809-2817.
25. Huynh KK, Plumb JD, Downey GP, Valvano MA, Grinstein S. Inactivation of macrophage Rab7 by Burkholderia cenocepacia. J Innate Immun 2010, 2(6):522-533. 10.1159/000319864, 2982851, 20829607.
26. Keith KE, Hynes DW, Sholdice JE, Valvano MA. Delayed association of the NADPH oxidase complex with macrophage vacuoles containing the opportunistic pathogen Burkholderia cenocepacia. Microbiology 2009, 155(Pt 4):1004-1015.
27. Natale DA, Galperin MY, Tatusov RL, Koonin EV. Using the COG database to improve gene recognition in complete genomes. Genetica 2000, 108(1):9-17. 10.1023/A:1004031323748, 11145426.
28. Aubert DF, Flannagan RS, Valvano MA. A novel sensor kinase-response regulator hybrid controls biofilm formation and type VI secretion system activity in Burkholderia cenocepacia. Infect Immun 2008, 76(5):1979-1991. 10.1128/IAI.01338-07, 2346693, 18316384.
29. Tatusov RL, Galperin MY, Natale DA, Koonin EV. The COG database: a tool for genome-scale analysis of protein functions and evolution. Nucleic Acids Res 2000, 28(1):33-36. 10.1093/nar/28.1.33, 102395, 10592175.
30. Hamad MA, Skeldon AM, Valvano MA. Construction of aminoglycoside-sensitive Burkholderia cenocepacia strains for use in studies of intracellular bacteria with the gentamicin protection assay. Appl Environ Microbiol 2010, 76(10):3170-3176. 10.1128/AEM.03024-09, 2869153, 20348312.
31. Faucher SP, Mueller CA, Shuman HA. Legionella pneumophila transcriptome during intracellular multiplication in human macrophages. Front Microbiol 2011, 2:60. 3128937, 21747786.
32. Graham JE, Clark-Curtiss JE. Identification of Mycobacterium tuberculosis RNAs synthesized in response to phagocytosis by human macrophages by selective capture of transcribed sequences (SCOTS). Proc Natl Acad Sci USA 1999, 96(20):11554-11559. 10.1073/pnas.96.20.11554, 18072, 10500215.
33. Daigle F, Graham JE, Curtiss R. Identification of Salmonella typhi genes expressed within macrophages by selective capture of transcribed sequences (SCOTS). Mol Microbiol 2001, 41(5):1211-1222.
34. Faucher SP, Porwollik S, Dozois CM, McClelland M, Daigle F. Transcriptome of Salmonella enterica serovar Typhi within macrophages revealed through the selective capture of transcribed sequences. Proc Natl Acad Sci USA 2006, 103(6):1906-1911. 10.1073/pnas.0509183103, 1413645, 16443683.
35. Poirier K, Faucher SP, Beland M, Brousseau R, Gannon V, Martin C, Harel J, Daigle F. Escherichia coli O157:H7 survives within human macrophages: global gene expression profile and involvement of the Shiga toxins. Infect Immun 2008, 76(11):4814-4822. 10.1128/IAI.00446-08, 2573336, 18725421.
36. Emboule L, Daigle F, Meyer DF, Mari B, Pinarello V, Sheikboudou C, Magnone V, Frutos R, Viari A, Barbry P, et al. Innovative approach for transcriptomic analysis of obligate intracellular pathogen: selective capture of transcribed sequences of Ehrlichia ruminantium. BMC Mol Biol 2009, 10:111. 10.1186/1471-2199-10-111, 2806407, 20034374.
37. Maloney KE, Valvano MA. The mgtC gene of Burkholderia cenocepacia is required for growth under magnesium limitation conditions and intracellular survival in macrophages. Infect Immun 2006, 74(10):5477-5486. 10.1128/IAI.00798-06, 1594880, 16988222.
38. Hunt TA, Kooi C, Sokol PA, Valvano MA. Identification of Burkholderia cenocepacia genes required for bacterial survival in vivo. Infect Immun 2004, 72(7):4010-4022. 10.1128/IAI.72.7.4010-4022.2004, 427415, 15213146.
39. Malott RJ, Baldwin A, Mahenthiralingam E, Sokol PA. Characterization of the cciIR quorum-sensing system in Burkholderia cenocepacia. Infect Immun 2005, 73(8):4982-4992. 10.1128/IAI.73.8.4982-4992.2005, 1201253, 16041013.
40. O'Grady EP, Viteri DF, Malott RJ, Sokol PA. Reciprocal regulation by the CepIR and CciIR quorum sensing systems in Burkholderia cenocepacia. BMC Genomics 2009, 10:441. 10.1186/1471-2164-10-441, 2753556, 19761612.
41. Sass A, Marchbank A, Tullis E, Lipuma JJ, Mahenthiralingam E. Spontaneous and evolutionary changes in the antibiotic resistance of Burkholderia cenocepacia observed by global gene expression analysis. BMC Genomics 2011, 12(1):373. 10.1186/1471-2164-12-373, 3155924, 21781329.
42. Naderer T, McConville MJ. The Leishmania-macrophage interaction: a metabolic perspective. Cell Microbiol 2008, 10(2):301-308.
43. Fukuto HS, Svetlanov A, Palmer LE, Karzai AW, Bliska JB. Global gene expression profiling of Yersinia pestis replicating inside macrophages reveals the roles of a putative stress-induced operon in regulating type III secretion and intracellular cell division. Infect Immun 2010, 78(9):3700-3715. 10.1128/IAI.00062-10, 2937462, 20566693.
44. Sokol PA, Darling P, Woods DE, Mahenthiralingam E, Kooi C. Role of ornibactin biosynthesis in the virulence of Burkholderia cepacia: characterization of pvdA, the gene encoding L-ornithine N(5)-oxygenase. Infect Immun 1999, 67(9):4443-4455. 96763, 10456885.
45. Taylor CM, Osman D, Cavet JS. Differential expression from two iron-responsive promoters in Salmonella enterica serovar Typhimurium reveals the presence of iron in macrophage-phagosomes. Microb Pathog 2009, 46:114-118. 10.1016/j.micpath.2008.11.001, 19049822.
46. Van Zandt KE, Sow FB, Florence WC, Zwilling BS, Satoskar AR, Schlesinger LS, Lafuse WP. The iron export protein ferroportin 1 is differentially expressed in mouse macrophage populations and is present in the mycobacterial-containing phagosome. J Leukoc Biol 2008, 84:689-700. 10.1189/jlb.1107781, 2516892, 18586980.
47. Wagner D, Maser J, Lai B, Cai Z, Barry CE, Höner zu Bentrup K, Russell DG, Bermudez LE. Elemental analysis of Mycobacterium avium-, Mycobacterium tuberculosis-, and Mycobacterium smegmatis -containing phagosomes indicates pathogen-induced microenvironments within the host cell's endosomal system. J Immunol 2005, 174:1491-1500.
48. Schmerk CL, Bernards MA, Valvano MA. Hopanoid production is required for low pH tolerance, antimicrobial resistance, and motility in Burkholderia cenocepacia. J Bacteriol 2011,
49. Welander PV, Hunter RC, Zhang L, Sessions AL, Summons RE, Newman DK. Hopanoids play a role in membrane integrity and pH homeostasis in Rhodopseudomonas palustris TIE-1. J Bacteriol 2009, 191:6145-6156. 10.1128/JB.00460-09, 2747905, 19592593.
50. Burchmore RJ, Barrett MP. Life in vacuoles--nutrient acquisition by Leishmania amastigotes. Int J Parasitol 2001, 31(12):1311-1320. 10.1016/S0020-7519(01)00259-4, 11566299.
51. Liu X, Matsumura P. The FlhD/FlhC complex, a transcriptional activator of the Escherichia coli flagellar class II operons. J Bacteriol 1994, 176(23):7345-7351. 197124, 7961507.
52. Porter SL, Wadhams GH, Armitage JP. Signal processing in complex chemotaxis pathways. Nat Rev Microbiol 2011, 9(3):153-165. 10.1038/nrmicro2505, 21283116.
53. Szurmant H, Muff TJ, Ordal GW. Bacillus subtilis CheC and FliY are members of a novel class of CheY-P-hydrolyzing proteins in the chemotactic signal transduction cascade. J Biol Chem 2004, 279(21):21787-21792. 10.1074/jbc.M311497200, 14749334.
54. Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res 2000, 28(1):27-30. 10.1093/nar/28.1.27, 102409, 10592173.
55. Kanehisa M, Goto S, Furumichi M, Tanabe M, Hirakawa M. KEGG for representation and analysis of molecular networks involving diseases and drugs. Nucleic Acids Res 2010, 38(Database):D355-360. 10.1093/nar/gkp896, 2808910, 19880382.
56. Chuaygud T, Tungpradabkul S, Sirisinha S, Chua KL, Utaisincharoen P. A role of Burkholderia pseudomallei flagella as a virulent factor. Trans R Soc Trop Med Hyg 2008, 102(Suppl 1):S140-144.
57. Amiel E, Lovewell RR, O'Toole GA, Hogan DA, Berwin B. Pseudomonas aeruginosa evasion of phagocytosis is mediated by loss of swimming motility and is independent of flagellum expression. Infect Immun 2010, 78(7):2937-2945. 10.1128/IAI.00144-10, 2897393, 20457788.
58. Urban TA, Griffith A, Torok AM, Smolkin ME, Burns JL, Goldberg JB. Contribution of Burkholderia cenocepacia flagella to infectivity and inflammation. Infect Immun 2004, 72(9):5126-5134. 10.1128/IAI.72.9.5126-5134.2004, 517433, 15322006.
59. Ortega XP, Cardona ST, Brown AR, Loutet SA, Flannagan RS, Campopiano DJ, Govan JR, Valvano MA. A putative gene cluster for aminoarabinose biosynthesis is essential for Burkholderia cenocepacia viability. J Bacteriol 2007, 189(9):3639-3644. 10.1128/JB.00153-07, 1855895, 17337576.
60. Roy H. Tuning the properties of the bacterial membrane with aminoacylated phosphatidylglycerol. IUBMB Life 2009, 61(10):940-953. 10.1002/iub.240, 2757517, 19787708.
61. Nelson J, Gibbons E, Pickett KR, Streeter M, Warcup AO, Yeung CH, Judd AM, Bell JD. Relationship between membrane permeability and specificity of human secretory phospholipase A(2) isoforms during cell death. Biochim Biophys Acta 2011, 1808(7):1913-1920. 10.1016/j.bbamem.2011.04.003, 21510917.
62. Cheung KJ, Li G, Urban TA, Goldberg JB, Griffith A, Lu F, Burns JL. Pilus-mediated epithelial cell death in response to infection with Burkholderia cenocepacia. Microbes Infect 2007, 9(7):829-837. 10.1016/j.micinf.2007.03.001, 17537663.
63. Cunha LG, Assis MC, Machado GB, Assef AP, Marques EA, Leao RS, Saliba AM, Plotkowski MC. Potential mechanisms underlying the acute lung dysfunction and bacterial extrapulmonary dissemination during Burkholderia cenocepacia respiratory infection. Respir Res 2010, 11:4. 10.1186/1465-9921-11-4, 2817657, 20082687.
64. McClean S, Callaghan M. Burkholderia cepacia complex: epithelial cell-pathogen confrontations and potential for therapeutic intervention. J Med Microbiol 2009, 58(Pt 1):1-12.
65. MacDonald KL, Speert DP. Differential modulation of innate immune cell functions by the Burkholderia cepacia complex: Burkholderia cenocepacia but not Burkholderia multivorans disrupts maturation and induces necrosis in human dendritic cells. Cell Microbiol 2008, 10(10):2138-2149. 10.1111/j.1462-5822.2008.01197.x, 18624797.
66. Cremer TJ, Shah P, Cormet-Boyaka E, Valvano MA, Butchar JP, Tridandapani S. Akt-Mediated Proinflammatory Response of Mononuclear Phagocytes Infected with Burkholderia cenocepacia Occurs by a Novel GSK3{beta}-Dependent, I{kappa}B Kinase-Independent Mechanism. J Immunol 2011,
67. Kotrange S, Kopp B, Akhter A, Abdelaziz D, Abu Khweek A, Caution K, Abdulrahman B, Wewers MD, McCoy K, Marsh C, et al. Burkholderia cenocepacia O polysaccharide chain contributes to caspase-1-dependent IL-1beta production in macrophages. J Leukoc Biol 2011, 89(3):481-488. 10.1189/jlb.0910513, 21178113.
68. Figurski DH, Helinski DR. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci USA 1979, 76(4):1648-1652. 10.1073/pnas.76.4.1648, 383447, 377280.
69. Sambrook J, Fritsch EF, Maniatis T. Molecular Cloning: a Laboratory Manual. 1990, Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 2.
70. Cohen SN, Chang AC, Hsu L. Nonchromosomal antibiotic resistance in bacteria: genetic transformation of Escherichia coli by R-factor DNA. Proc Natl Acad Sci USA 1972, 69(8):2110-2114. 10.1073/pnas.69.8.2110, 426879, 4559594.
71. Froussard P. A random-PCR method (rPCR) to construct whole cDNA library from low amounts of RNA. Nucleic Acids Res 1992, 20(11):2900. 10.1093/nar/20.11.2900, 336952, 1614887.
72. Daigle F, Hou JY, Clark-Curtiss JE. Microbial gene expression elucidated by selective capture of transcribed sequences (SCOTS). Methods Enzymol 2002, 358:108-122.
73. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 2000, 132:365-386.
74. Flannagan RS, Linn T, Valvano MA. A system for the construction of targeted unmarked gene deletions in the genus Burkholderia. Environ Microbiol 2008, 10(6):1652-1660. 10.1111/j.1462-2920.2008.01576.x, 18341581.
75. Miller VL, Mekalanos JJ. A novel suicide vector and its use in construction of insertion mutations: osmoregulation of outer membrane proteins and virulence determinants in Vibrio cholerae requires toxR. J Bacteriol 1988, 170(6):2575-2583. 211174, 2836362.
76. Cox GW, Mathieson BJ, Gandino L, Blasi E, Radzioch D, Varesio L. Heterogeneity of hematopoietic cells immortalized by v-myc/v-raf recombinant retrovirus infection of bone marrow or fetal liver. J Natl Cancer Inst 1989, 81(19):1492-1496. 10.1093/jnci/81.19.1492, 2778838.
77. Aubert D, MacDonald DK, Valvano MA. BcsKC is an essential protein for the type VI secretion system activity in Burkholderia cenocepacia that forms an outer membrane complex with BcsLB. J Biol Chem 2010, 285(46):35988-35998. 10.1074/jbc.M110.120402, 2975221, 20729192.
78. Yanisch-Perron C, Vieira J, Messing J. Improved M13 phage cloning vectors and host strains: nucleotide sequences of the M13mp18 and pUC19 vectors. Gene 1985, 33(1):103-119. 10.1016/0378-1119(85)90120-9, 2985470.